For the year ending 2025-12-31, AGEN made $114,196K in revenue. -$101K in net income. Net profit margin of -0.09%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 114,196 | |||
| Cost of revenue | 1,022 | |||
| Research and development | 79,338 | |||
| General and administrative | 54,392 | |||
| Fair value adjustments | 387 | |||
| Operating loss | -20,169 | |||
| Non-operating income (expense) | -2,220 | |||
| Mink therapeutics, inc. equity method investment fair value adjustment | -26,345 | |||
| Gain from deconsolidation of mink therapeutics, inc | 100,924 | |||
| Interest expense, net | -55,273 | |||
| Net loss | -3,083 | |||
| Dividends on series a-1 convertible preferred stock | 216 | |||
| Less net loss attributable to non-controlling interest | -3,198 | |||
| Net loss attributable to agenus inc. common stockholders | -101 | |||
| Basic EPS | 0 | |||
| Diluted EPS | 0 | |||
| Basic Average Shares | 29,734,000 | |||
| Diluted Average Shares | 29,734,000 | |||
AGENUS INC (AGEN)
AGENUS INC (AGEN)